111130 ⎘
ssRNA viruses positive-sense; Details Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
CORONAVIRUS VACCINES
#2METHOD FOR PRODUCING ALFALFA MOSAIC VIRUS-LIKE PARTICLES USING PLANT EXPRESSION SYSTEM AND USE THEREOF
#3TOBACCO MOSAIC VIRUS DELIVERY OF MITOXANTRONE FOR CANCER THERAPY
#4ANTICANCER DRUG-CONTAINING PLANT VIRUS PARTICLES
#5VETERINARY VIRAL VECTOR
#6TOBAMOVIRUS PSEUDOVIRIONS FOR STABILISING SINGLE STRANDED RNA
#7COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES AGAINST CLASS I FUSION PROTEIN VIRUSES
#8CANCER IMMUNOTHERAPY USING VIRUS PARTICLES
#9Cancer immunotherapy using virus particles
#10PURIFICATION METHOD FOR VACCINE VIRUS USING AFFINITY CHROMATOGRAPHY
#11Cancer immunotherapy using virus particles
#12Protective interfering nucleic acid molecule and virus-like particle, viral vector, or virus particle containing the same as well as pharmaceutical composition containing the protective interfering nucleic acid and its use
#13Chimeric yellow fever ZIKA virus strain
#14Anticancer drug-containing plant virus particles
#15Methods to identify prime and boost immunogens for use in a B cell lineage-based vaccination protocol
#16Anticancer drug-containing plant virus particles
#17Methods and compositions for liposomal formulation of antigens and uses thereof
#18Bird flu vaccine combination comprising virus-like particles and novel adjuvants
#19Cancer immunotherapy using virus particles
#20Viral based transient-expression vector system that allows multiple applications
#21Methods and compositions for liposomal formulation of antigens and uses thereof
#22Cellular vaccine and method of inducing an immune response in a subject
#23USE OF RAPAMYCIN AS VACCINE ADJUVANT AND PREPARATION METHOD THEREFOR
#24REVERSE VACCINATION THERAPY OF MULTIPLE SCLEROSIS
#25HIV-1 vaccine
#26Cellular vaccine and method of inducing an immune response in a subject
#27Chimeric non-integrating lentiviral genomes as vaccines against HIV-1
#28GP120 immunogens and methods inducing neutralizing antibodies to human immunodeficiency virus
#29POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
#30Methods and compositions for liposomal formulation of antigens and uses thereof
#31Method for Removing Immunosuppressive Properties of HIV Envelope Glycoproteins
#32Viral based transient-expression vector system that allows multiple applications
#33Viral based transient-expression vector system that allows multiple applications
#34Methods and compositions for liposomal formulation of antigens and uses thereof